spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, H.
Right arrow Articles by Iruela-Arispe, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, H.
Right arrow Articles by Iruela-Arispe, M. L.

Development, Vol 126, Issue 16 3597-3605, Copyright © 1999 by Company of Biologists

JOURNAL ARTICLES

Inactivation of erythropoietin leads to defects in cardiac morphogenesis

H Wu, SH Lee, J Gao, X Liu and ML Iruela-Arispe
Howard Hughes Medical Institute and Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, CA 90095-1735, USA.

Erythropoietin is an essential growth factor that promotes survival, proliferation, and differentiation of mammalian erythroid progenitor cells. Erythropoietin(-/-) and erythropoietin receptor(-/-) mouse embryos die around embryonic day 13.5 due, in part, to failure of erythropoiesis in the fetal liver. In this study, we demonstrated a novel role of erythropoietin and erythropoietin receptor in cardiac development in vivo. We found that erythropoietin receptor is expressed in the developing murine heart in a temporal and cell type-specific manner: it is initially detected by embryonic day 10.5 and persists until day 14.5. Both erythropoietin(-/-) and erythropoietin receptor(-/-) embryos suffered from ventricular hypoplasia at day 12-13 of gestation. This defect appears to be independent from the general state of hypoxia and is likely due to a reduction in the number of proliferating cardiac myocytes in the ventricular myocardium. Cell proliferation assays revealed that erythropoietin acts as a mitogen in cells isolated from erythropoietin(-/-) mice, while it has no effect in hearts from erythropoietin receptor(-/-) animals. Erythropoietin(-/-) and erythropoietin receptor(-/-) embryos also suffered from epicardium detachment and abnormalities in the vascular network. Finally, through a series of chimeric analysis, we provided evidence that erythropoietin acts in a manner which is non-cell-autonomous. Our results elucidate a novel role of erythropoietin in cardiac morphogenesis and suggest a combination of anemia and cardiac failure as the cause of embryonic lethality in the erythropoietin(-/-) and erythropoietin receptor(-/-) animals.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. A. Ream, R. Chandra, M. Peavey, A. M. Ray, S. Roffler-Tarlov, H.-G. Kim, W. C. Wetsel, H. A. Rockman, and D. M. Chikaraishi
High oxygen prevents fetal lethality due to lack of catecholamines
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R942 - R953.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Ream, A. M. Ray, R. Chandra, and D. M. Chikaraishi
Early fetal hypoxia leads to growth restriction and myocardial thinning
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R583 - R595.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K.-H. Kim, G. Y. Oudit, and P. H. Backx
Erythropoietin Protects against Doxorubicin-Induced Cardiomyopathy via a Phosphatidylinositol 3-Kinase-Dependent Pathway
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 160 - 169.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Paffett-Lugassy, N. Hsia, P. G. Fraenkel, B. Paw, I. Leshinsky, B. Barut, N. Bahary, J. Caro, R. Handin, and L. I. Zon
Functional conservation of erythropoietin signaling in zebrafish
Blood, October 1, 2007; 110(7): 2718 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Ferrario, M. Massa, V. Rosti, R. Campanelli, M. Ferlini, B. Marinoni, G. M. De Ferrari, V. Meli, M. De Amici, A. Repetto, et al.
Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction
Eur. Heart J., August 1, 2007; 28(15): 1805 - 1813.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P. Madeddu and C. Emanueli
Switching on Reparative Angiogenesis: Essential Role of the Vascular Erythropoietin Receptor
Circ. Res., March 16, 2007; 100(5): 599 - 601.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H. Tada, Y. Kagaya, M. Takeda, J. Ohta, Y. Asaumi, K. Satoh, K. Ito, A. Karibe, K. Shirato, N. Minegishi, et al.
Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion
Cardiovasc Res, August 1, 2006; 71(3): 466 - 477.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Dame, K. M. Kirschner, K. V. Bartz, T. Wallach, C. S. Hussels, and H. Scholz
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene
Blood, June 1, 2006; 107(11): 4282 - 4290.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Y.-D. Tang and S. D. Katz
Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options
Circulation, May 23, 2006; 113(20): 2454 - 2461.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
K. Fukuda and S. Yuasa
Stem Cells as a Source of Regenerative Cardiomyocytes
Circ. Res., April 28, 2006; 98(8): 1002 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Ito, N. Arimitsu, M. Takeuchi, N. Kawamura, M. Nagata, K. Saso, N. Akimitsu, H. Hamamoto, S. Natori, A. Miyajima, et al.
Transcription Elongation Factor S-II Is Required for Definitive Hematopoiesis
Mol. Cell. Biol., April 15, 2006; 26(8): 3194 - 3203.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. A Calhoun, S N. Murthy, B. G Bryant, S. A Luedtke, and V. Bhatt-Mehta
Recent Advances in Neonatal Pharmacotherapy
Ann. Pharmacother., April 1, 2006; 40(4): 710 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. T. Tsai, J. J. Ohab, N. Kertesz, M. Groszer, C. Matter, J. Gao, X. Liu, H. Wu, and S. T. Carmichael
A Critical Role of Erythropoietin Receptor in Neurogenesis and Post-Stroke Recovery
J. Neurosci., January 25, 2006; 26(4): 1269 - 1274.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. E. Hardee, M. O. Arcasoy, K. L. Blackwell, J. P. Kirkpatrick, and M. W. Dewhirst
Erythropoietin Biology in Cancer
Clin. Cancer Res., January 15, 2006; 12(2): 332 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Muller-Ehmsen, A. Schmidt, B. Krausgrill, R. H. G. Schwinger, and W. Bloch
Role of erythropoetin for angiogenesis and vasculogenesis: from embryonic development through adulthood
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H331 - H340.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Merki, M. Zamora, A. Raya, Y. Kawakami, J. Wang, X. Zhang, J. Burch, S. W. Kubalak, P. Kaliman, J. C. I. Belmonte, et al.
From the Cover: Epicardial retinoid X receptor {alpha} is required for myocardial growth and coronary artery formation
PNAS, December 20, 2005; 102(51): 18455 - 18460.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Rossert and K.-U. Eckardt
Erythropoietin receptors: their role beyond erythropoiesis
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1025 - 1028.
[Full Text] [PDF]

Home page
 Vasc MedHome page
H. Mu, R. Ohashi, P. Lin, Q. Yao, and C. Chen
Cellular and molecular mechanisms of coronary vessel development
Vascular Medicine, February 1, 2005; 10(1): 37 - 44.
[Abstract] [PDF]

Home page
 Genes Dev.Home page
Z. Wang, W. Zhai, J. A. Richardson, E. N. Olson, J. J. Meneses, M. T. Firpo, C. Kang, W. C. Skarnes, and R. Tjian
Polybromo protein BAF180 functions in mammalian cardiac chamber maturation
Genes & Dev., December 15, 2004; 18(24): 3106 - 3116.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Cuzzocrea, E. Mazzon, R. Di Paola, N. S. A. Patel, T. Genovese, C. Muia, A. De Sarro, and C. Thiemermann
Erythropoietin Reduces the Development of Experimental Inflammatory Bowel Disease
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1272 - 1280.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. J. Foster, O. W. Moe, and C. C. W. Hsia
Upregulation of erythropoietin receptor during postnatal and postpneumonectomy lung growth
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1107 - L1115.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. Fraidenraich, E. Stillwell, E. Romero, D. Wilkes, K. Manova, C. T. Basson, and R. Benezra
Rescue of Cardiac Defects in Id Knockout Embryos by Injection of Embryonic Stem Cells
Science, October 8, 2004; 306(5694): 247 - 252.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. B. Beleslin-Cokic, V. P. Cokic, X. Yu, B. B. Weksler, A. N. Schechter, and C. T. Noguchi
Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
Blood, October 1, 2004; 104(7): 2073 - 2080.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Fandrey
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R977 - R988.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
R. W. Stottmann, M. Choi, Y. Mishina, E. N. Meyers, and J. Klingensmith
BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium
Development, May 1, 2004; 131(9): 2205 - 2218.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
B. C. Heng, H. K. Haider, E. K.-W. Sim, T. Cao, and S. C. Ng
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro
Cardiovasc Res, April 1, 2004; 62(1): 34 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
P. van der Meer, A. A. Voors, E. Lipsic, W. H. van Gilst, and D. J. van Veldhuisen
Erythropoietin in cardiovascular diseases
Eur. Heart J., February 2, 2004; 25(4): 285 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. J Smith, A. J Bleyer, W. C Little, and D. C Sane
The cardiovascular effects of erythropoietin
Cardiovasc Res, September 1, 2003; 59(3): 538 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
E. N. Olson and M. D. Schneider
Sizing up the heart: development redux in disease
Genes & Dev., August 15, 2003; 17(16): 1937 - 1956.
[Full Text] [PDF]

Home page
 BloodHome page
C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A. M. Zeiher, and S. Dimmeler
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Blood, August 15, 2003; 102(4): 1340 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. J. Solloway and R. P. Harvey
Molecular pathways in myocardial development: a stem cell perspective
Cardiovasc Res, May 1, 2003; 58(2): 264 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Sachinidis, B. K. Fleischmann, E. Kolossov, M. Wartenberg, H. Sauer, and J. Hescheler
Cardiac specific differentiation of mouse embryonic stem cells
Cardiovasc Res, May 1, 2003; 58(2): 278 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Calvillo, R. Latini, J. Kajstura, A. Leri, P. Anversa, P. Ghezzi, M. Salio, A. Cerami, and M. Brines
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
PNAS, April 15, 2003; 100(8): 4802 - 4806.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
X. Yu, J. J. Shacka, J. B. Eells, C. Suarez-Quian, R. M. Przygodzki, B. Beleslin-Cokic, C.-S. Lin, V. M. Nikodem, B. Hempstead, K. C. Flanders, et al.
Erythropoietin receptor signalling is required for normal brain development
Development, March 3, 2003; 129(2): 505 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Suzuki, O. Ohneda, S. Takahashi, M. Higuchi, H. Y. Mukai, T. Nakahata, S. Imagawa, and M. Yamamoto
Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality
Blood, September 18, 2002; 100(7): 2279 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 J Hum LactHome page
R. D. Semba and S. E. Juul
Erythropoietin in Human Milk: Physiology and Role in Infant Health
J Hum Lact, August 1, 2002; 18(3): 252 - 261.
[Abstract] [PDF]

Home page
 Circ. Res.Home page
K. B.S. Pasumarthi and L. J. Field
Cardiomyocyte Cell Cycle Regulation
Circ. Res., May 31, 2002; 90(10): 1044 - 1054.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. G. Jegalian, A. Acurio, G. Dranoff, and H. Wu
Erythropoietin receptor haploinsufficiency and in vivo interplay with granulocyte-macrophage colony-stimulating factor and interleukin 3
Blood, April 1, 2002; 99(7): 2603 - 2605.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. G. Spencer, S. Orita, C. J. Malone, and M. Han
A RHO GTPase-mediated pathway is required during P cell migration in Caenorhabditis elegans
PNAS, October 25, 2001; (2001) 241504098.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Lee, N. Kertesz, S. B. Joseph, A. Jegalian, and H. Wu
Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis
Blood, September 1, 2001; 98(5): 1408 - 1415.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X. Yu, C.-S. Lin, F. Costantini, and C. T. Noguchi
The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse
Blood, July 15, 2001; 98(2): 475 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
D. L. Ramirez-Bergeron and M. C. Simon
Hypoxia-Inducible Factor and the Development of Stem Cells of the Cardiovascular System
Stem Cells, July 1, 2001; 19(4): 279 - 286.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. S. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, R. Baruch, D. Schwartz, T. Yachnin, S. Steinbruch, I. Shapira, et al.
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1775 - 1780.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Divoky, Z. Liu, T. M. Ryan, J. F. Prchal, T. M. Townes, and J. T. Prchal
Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene
PNAS, January 30, 2001; 98(3): 986 - 991.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Ogilvie, X. Yu, V. Nicolas-Metral, S. M. Pulido, C. Liu, U. T. Ruegg, and C. T. Noguchi
Erythropoietin Stimulates Proliferation and Interferes with Differentiation of Myoblasts
J. Biol. Chem., December 8, 2000; 275(50): 39754 - 39761.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. G. Spencer, S. Orita, C. J. Malone, and M. Han
A RHO GTPase-mediated pathway is required during P cell migration in Caenorhabditis elegans
PNAS, November 6, 2001; 98(23): 13132 - 13137.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 1999